Fetuin-A/Albumin-Mineral Complexes Resembling Serum Calcium Granules and Putative Nanobacteria: Demonstration of a Dual Inhibition-Seeding Concept

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Wu, Cheng Yeu ^a   Martel, Jan ^a   Young, David ^a,b   Young, John D ^a,c,d  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d MING CHI UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINOID; ALPHA FETOPROTEIN; APATITE; CALCIUM; NANOPARTICLE; PEPTIDE HYDROLASE; PHOSPHATE;

ARTICLE; CHEMISTRY; CRYSTALLIZATION; GEL; HEAT; HUMAN; KINETICS; METABOLISM; METHODOLOGY; NANOTECHNOLOGY; PROTEIN CONFORMATION; RAMAN SPECTROMETRY; SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY;

ALBUMINS; ALPHA-FETOPROTEINS; APATITES; CALCIUM; CRYSTALLIZATION; GELS; HOT TEMPERATURE; HUMANS; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NANOTECHNOLOGY; PEPTIDE HYDROLASES; PHOSPHATES; PROTEIN CONFORMATION; SPECTROMETRY, X-RAY EMISSION; SPECTRUM ANALYSIS, RAMAN;

EID: 77951228505     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008058     Document Type: Article

References (223)

1. Martel J, Young JD, (2008) Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci U S A 105: 5549-5554.
2. Young JD, Martel J, Young L, Wu CY, Young A, et al.(2009) Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One 4: e4417.
3. Young JD, Martel J, Young D, Young A, Hung CM, et al.(2009) Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria. PLoS One 4: e5421.
4. Kajander EO, Kuronen I, Akerman K, Pelttari A, Ciftcioglu N, (1997) Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth. Proc Soc Photo Opt Instrum Eng 3111: 420-428.
5. Kajander EO, Ciftcioglu N, (1998) Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 95: 8274-8279.
6. Kajander EO, (2006) Nanobacteria-propagating calcifying nanoparticles. Lett Appl Microbiol 42: 549-552.
7. Ciftcioglu N, McKay DS, Mathew G, Kajander EO, (2006) Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles. J Investig Med 54: 385-394.
8. Ciftcioglu N, Bjorklund M, Kuorikoski K, Bergstrom K, Kajander EO, (1999) Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56: 1893-1898.
9. Kajander EO, Ciftcioglu N, Aho K, Garcia-Cuerpo E, (2003) Characteristics of nanobacteria and their possible role in stone formation. Urol Res 31: 47-54.
10. Ciftcioglu N, Aho KM, McKay DS, Kajander EO, (2007) Are apatite nanoparticles safe? Lancet 369: 2078.
11. Lieske JC, (2008) Can biologic nanoparticles initiate nephrolithiasis? Nature Clin Pract Nephrol 4: 308-309.
12. Shiekh FA, Miller VM, Lieske JC, (2009) Do calcifying nanoparticles promote nephrolithiasis? A review of the evidence. Clin Nephrol 71: 1-8.
13. Folk RL, (1993) SEM imaging of bacteria and nannobacteria in carbonate sediments and rocks. J Sediment Petrol 63: 990-999.
14. Sillitoe RH, Folk RL, Sarie N, (1996) Bacteria as mediators of copper sulfide enrichment during weathering. Science 272: 1153-1155.
15. Sommer AP, Gheorghiu E, Cehreli M, Mester AR, Whelan HT, (2006) Biosensor for detection of nanobacteria in water. Cryst Growth Des 6: 492-497.
16. Smirnov GV, Smirnov DG, (2008) Nannobacteria, a new ecological threat. Contemp Prob Ecol 1: 111-114.
17. Sommer AP, Wickramasinghe NC, (2005) Functions and possible provenance of primordial proteins-Part II: microorganism aggregation in clouds triggered by climate change. J Proteome Res 4: 180-184.
18. McKay DS, Gibson EK Jr, Thomas-Keprta KL, Vali H, Romanek CS, et al.(1996) Search for past life on Mars: possible relic biogenic activity in martian meteorite ALH84001. Science 273: 924-930.
19. Wainwright M, Wickramasinghe NC, Narlikar JV, Rajaratnam P, (2003) Microorganisms cultured from stratospheric air samples obtained at 41 km. FEMS Microbiol Lett 218: 161-165.
20. Wainwright M, Wickramasinghe NC, Narlikar JV, Rajaratnam P, (2004) Are these stratospheric nanoparticles bacteria? Microbiology 150: 756-758.
21. Wickramasinghe JT, Wickramasinghe NC, (2006) A cosmic prevalence of nanobacteria? Astrophys Space Sci 305: 411-413.
22. Ciftcioglu N, Kuronen I, Akerman K, Hiltunen E, Laukkanen J, et al.(1997) A new potential threat in antigen and antibody products: nanobacteria. In: Brown F, Burton D, Doherty P, Mekalanos J, Norrby E, editors. Vaccines 97. Molecular approaches to the control of infectious diseases New York Cold Spring Harbor Laboratory Press pp. 99-103.
23. Carson DA, (1998) An infectious origin of extraskeletal calcification. Proc Natl Acad Sci U S A 95: 7846-7847.
24. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, et al.(2000) Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 57: 2360-2374.
25. Dorrell S, (1999) Nanobacteria linked to kidney disease. Mol Med Today 5: 373.
26. Kumar V, Farell G, Yu S, Harrington S, Fitzpatrick L, et al.(2006) Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Investig Med 54: 412-424.
27. Ciftcioglu N, Vejdani K, Lee O, Mathew G, Aho KM, et al.(2008) Association between Randall's plaque and calcifying nanoparticles. Int J Nanomedicine 3: 105-115.
28. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, et al.(2004) Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287: H1115-1124.
29. Puskas LG, Tiszlavicz L, Razga Z, Torday LL, Krenacs T, et al.(2005) Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 56: 233-245.
30. Schwartz MA, Lieske JC, Kumar V, Farell-Baril G, Miller VM, (2008) Human-derived nanoparticles and vascular response to injury in rabbit carotid arteries: proof of principle. Int J Nanomedicine 3: 243-248.
31. Schwartz MK, Lieske JC, Hunter LW, Miller VM, (2009) Systemic injection of planktonic forms of mammalian-derived nanoparticles alters arterial response to injury in rabbits. Am J Physiol Heart Circ Physiol 296: H1434-1441.
32. Bratos-Perez MA, Sanchez PL, Garcia de Cruz S, Villacorta E, Palacios IF, et al.(2008) Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification. Eur Heart J 29: 371-376.
33. Maniscalco BS, Taylor KA, (2004) Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 11: 95-101.
34. Shoskes DA, Thomas KD, Gomez E, (2005) Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 173: 474-477.
35. Zhou Z, Hong L, Shen X, Rao X, Jin X, et al.(2008) Detection of nanobacteria infection in type III prostatitis. Urology 71: 1091-1095.
36. Garcia Cuerpo E, Kajander EO, Ciftcioglu N, Lovaco Castellano F, Correa C, et al.(2000) Nanobacteria. Un modelo de neo-litogenesis experimental. Arch Esp Urol 53: 291-303.
37. Wang L, Shen W, Wen J, An X, Cao L, et al.(2006) An animal model of black pigment gallstones caused by nanobacteria. Dig Dis Sci 51: 1126-1132.
38. Shiekh FA, Khullar M, Singh SK, (2006) Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 34: 53-57.
39. Jones JA, Ciftcioglu N, McKay D, (2008) The role of nanobacteria/calcifying nanoparticles in prostate disease. In: Shoskes DA, editors. Current clinical urology series, chronic prostatitis/chronic pelvic syndrome Totowa Humana Press pp. 221-243.
40. Sommer AP, Milankovits M, Mester AR, (2006) Nanobacteria, HIV and magic bullets-update of perspectives 2005. Chemotherapy 52: 95-97.
41. Sommer AP, Pavlath AE, (2006) Nanobioaerosols-reconsidering agricultural irrigation in a warming world. J Environ Monit 8: 341-346.
42. Aho K, Kajander EO, (2003) Pitfalls in detection of novel nanoorganisms. J Clin Microbiol 41: 3460-3461.
43. Urbano P, Urbano F, (2007) Nanobacteria: facts or fancies? PLoS Pathog 3: e55.
44. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, et al.(2000) An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci U S A 97: 11511-11515.
45. Drancourt M, Jacomo V, Lepidi H, Lechevallier E, Grisoni V, et al.(2003) Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J Clin Microbiol 41: 368-372.
46. Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, et al.(2008) Nanobacteria are mineralo fetuin complexes. PLoS Pathog 4: e41.
47. Kirkland BL, Lynch FL, Rahnis MA, Folk RL, Molineux IJ, et al.(1999) Alternative origins for nannobacteria-like objects in calcite. Geology 27: 347-350.
48. Garcia Ruiz JM, Carnerup A, Christy AG, Welham NJ, Hyde ST, (2002) Morphology: an ambiguous indicator of biogenicity. Astrobiology 2: 353-369.
49. Benzerara K, Menguy N, Guyot F, Dominici C, Gillet P, (2003) Nanobacteria-like calcite single crystals at the surface of the Tataouine meteorite. Proc Natl Acad Sci U S A 100: 7438-7442.
50. Garcia-Ruiz JM, Hyde ST, Carnerup AM, Christy AG, Van Kranendonk MJ, et al.(2003) Self-assembled silica-carbonate structures and detection of ancient microfossils. Science 302: 1194-1197.
51. Ryall RL, (2008) The future of stone research: rummagings in the attic, Randall's plaque, nanobacteria, and lessons from phylogeny. Urol Res 36: 77-97.
52. Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM, (2008) Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 73: 384-390.
53. Westenfeld R, Jahnen-Dechent W, Ketteler M, (2007) Vascular calcification and fetuin-A deficiency in chronic kidney disease. Trends Cardiovasc Med 17: 124-128.
54. Ketteler M, Westenfeld R, Schlieper G, Brandenburg V, Floege J, (2005) "Missing" inhibitors of calcification: general aspects and implications in renal failure. Pediatr Nephrol 20: 383-388.
55. Ketteler M, Brandenburg V, Jahnen-Dechent W, Westenfeld R, Floege J, (2005) Do not be misguided by guidelines: the calcium x phosphate product can be a Trojan horse. Nephrol Dial Transplant 20: 673-677.
56. Jahnen-Dechent W, Schafer C, Heiss A, Grotzinger J, (2001) Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin. Z Kardiol 90: 47-56.
57. Jahnen-Dechent W, (2004) Lot's wife's problem revisited: how we prevent pathological calcification. In: Baeuerlein E, editors. Biomineralization. Progress in biology, molecular biology and application Weinheim Wiley-VCH pp. 243-268.
58. Mann S, (2001) Chemical control of biomineralization. In: Mann S, editors. Biomineralization: principles and concepts in bioinorganic materials chemistry Oxford Oxford University Press pp. 38-67.
59. Saroff HA, Lewis MS, (1963) The binding of calcium ions to serum albumin. J Phys Chem 67: 1211-1216.
60. Fogh-Andersen N, (1977) Albumin/calcium association at different pH, as determined by potentiometry. Clin Chem 23: 2122-2126.
61. Besarab A, DeGuzman A, Swanson JW, (1981) Effect of albumin and free calcium concentrations on calcium binding in vitro. J Clin Pathol 34: 1361-1367.
62. Garnett J, Dieppe P, (1990) The effects of serum and human albumin on calcium hydroxyapatite crystal growth. Biochem J 266: 863-868.
63. Gilman H, Hukins DW, (1994) Seeded growth of hydroxyapatite in the presence of dissolved albumin. J Inorg Biochem 55: 21-30.
64. Gilman H, Hukins DW, (1994) Seeded growth of hydroxyapatite in the presence of dissolved albumin at constant composition. J Inorg Biochem 55: 31-39.
65. Suzuki M, Shimokawa H, Takagi Y, Sasaki S, (1994) Calcium-binding properties of fetuin in fetal bovine serum. J Exp Zool 270: 501-507.
66. Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, et al.(1996) The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271: 20789-20796.
67. Jahnen-Dechent W, Schinke T, Trindl A, Muller-Esterl W, Sablitzky F, et al.(1997) Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272: 31496-31503.
68. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, et al.(2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366.
69. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, et al.(2002) Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 277: 3926-3934.
70. Price PA, Nguyen TM, Williamson MK, (2003) Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem 278: 22153-22160.
71. Price PA, Lim JE, (2003) The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem 278: 22144-22152.
72. Price PA, Williamson MK, Nguyen TM, Than TN, (2004) Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 279: 1594-1600.
73. Heiss A, Jahnen-Dechent W, Endo H, Schwahn D, (2007) Structural dynamics of a colloidal protein-mineral complex bestowing on calcium phosphate a high solubility in biological fluids. Biointerphases 2: 16-20.
74. Heiss A, Eckert T, Aretz A, Richtering W, van Dorp W, et al.(2008) Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J Biol Chem 283: 14815-14825.
75. Jahnen-Dechent W, Schafer C, Ketteler M, McKee MD, (2008) Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 86: 379-389.
76. Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, et al.(2009) Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int 75: 915-928.
77. Komaba H, Fukagawa M, (2009) Fetuin-mineral complex: a new potential biomarker for vascular calcification? Kidney Int 75: 874-876.
78. Ashton BA, Triffitt JT, Herring GM, (1974) Isolation and partial characterization of a glycoprotein from bovine cortical bone. Eur J Biochem 45: 525-533.
79. Ohnishi T, Arakaki N, Nakamura O, Hirono S, Daikuhara Y, (1991) Purification, characterization, and studies on biosynthesis of a 59-kDa bone sialic acid-containing protein (BSP) from rat mandible using a monoclonal antibody. Evidence that 59-kDa BSP may be the rat counterpart of human alpha 2-HS glycoprotein and is synthesized by both hepatocytes and osteoblasts. J Biol Chem 266: 14636-14645.
80. Quelch KJ, Cole WG, Melick RA, (1984) Noncollagenous proteins in normal and pathological human bone. Calcif Tissue Int 36: 545-549.
81. Combes C, Rey C, Freche M, (1999) In vitro crystallization of octacalcium phosphate on type I collagen: influence of serum albumin. J Mater Sci Mater Med 10: 153-160.
82. Combes C, Rey C, (2002) Adsorption of proteins and calcium phosphate materials bioactivity. Biomaterials 23: 2817-2823.
83. Marques PA, Serro AP, Saramago BJ, Fernandes AC, Magalhaes MC, et al.(2003) Mineralisation of two phosphate ceramics in HBSS: role of albumin. Biomaterials 24: 451-460.
84. Marques PAAP, Cachinho SCP, Magalhaes MCF, Correia RN, Fernandes MHV, (2004) Mineralisation of bioceramics in simulated plasma with physiological CO2/HCO3- buffer and albumin. J Mater Chem 14: 1861-1866.
85. Ciftcioglu N, Kajander EO, (1998) Interaction of nanobacteria with cultured mammalian cells. Pathophysiology 4: 259-270.
86. Ciftcioglu N, Miller-Hjelle MA, Hjelle JT, Kajander EO, (2002) Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 46: 2077-2086.
87. Ciftcioglu N, Haddad RS, Golden DC, Morrison DR, McKay DS, (2005) A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity. Kidney Int 67: 483-491.
88. Khullar M, Sharma SK, Singh SK, Bajwa P, Sheikh FA, et al.(2004) Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol Res 32: 190-195.
89. Hudelist G, Singer CF, Kubista E, Manavi M, Mueller R, et al.(2004) Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 45: 633-637.
90. Wen Y, Li YG, Yang ZL, Wang XJ, Wei H, et al.(2005) Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J (Engl) 118: 421-424.
91. Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, et al.(2006) Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol 43: 1864-1871.
92. Wong F, (2007) Drug insight: the role of albumin in the management of chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 4: 43-51.
93. Johansson L, Klinth J, Holmqvist O, Ohlson S, (2003) Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotechnology 42: 67-74.
94. Heiss A, DuChesne A, Denecke B, Grotzinger J, Yamamoto K, et al.(2003) Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278: 13333-13341.
95. Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, et al.(2006) Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 52: 227-234.
96. Brown WM, Saunders NR, Mollgard K, Dziegielewska KM, (1992) Fetuin-an old friend revisited. Bioessays 14: 749-755.
97. Addadi L, Weiner S, (1985) Interactions between acidic proteins and crystals: Stereochemical requirements in biomineralization. Proc Natl Acad Sci U S A 82: 4110-4114.
98. Lussi A, Crenshaw MA, Linde A, (1988) Induction and inhibition of hydroxyapatite formation by rat dentine phosphoprotein in vitro. Arch Oral Biol 33: 685-691.
99. Boskey AL, (1991) The role of extracellular matrix components in dentin mineralization. Crit Rev Oral Biol Med 2: 369-387.
100. Benesch J, Mano JF, Reis RL, (2008) Proteins and their peptide motifs in acellular apatite mineralization of scaffolds for tissue engineering. Tissue Eng Part B Rev 14: 433-445.
101. Mann S, (1988) Molecular recognition in biomineralization. Nature 332: 119-124.
102. Linde A, Lussi A, Crenshaw MA, (1989) Mineral induction by immobilized polyanionic proteins. Calcif Tissue Int 44: 286-295.
103. Martin RI, Brown PW, (1994) Formation of hydroxyapatite in serum. J Mat Sc Mat Med 5: 96-102.
104. Tsortos A, Ohki S, Zieba A, Baier RE, Nancollas GH, (1996) The dual role of fibrinogen as inhibitor and nucleator of calcium phosphate phases: the importance of structure. J Colloid Interface Sci 177: 257-262.
105. Serro AP, Fernandes AC, Saramago B, Lima J, Barbosa MA, (1997) Apatite deposition on titanium surfaces-the role of albumin adsorption. Biomaterials 18: 963-968.
106. Rohanizadeh R, Padrines M, Bouler JM, Couchourel D, Fortun Y, et al.(1998) Apatite precipitation after incubation of biphasic calcium-phosphate ceramic in various solutions: influence of seed species and proteins. J Biomed Mater Res 42: 530-539.
107. Daculsi G, Pilet P, Cottrel M, Guicheux G, (1999) Role of fibronectin during biological apatite crystal nucleation: ultrastructural characterization. J Biomed Mater Res 47: 228-233.
108. Beshensky AM, Wesson JA, Worcester EM, Sorokina EJ, Snyder CJ, et al.(2001) Effects of urinary macromolecules on hydroxyapatite crystal formation. J Am Soc Nephrol 12: 2108-2116.
109. Wen HB, Moradian-Oldak J, (2003) Modification of calcium-phosphate coatings on titanium by recombinant amelogenin. J Biomed Mater Res A 64: 483-490.
110. Areva S, Peltola T, Sailynoja E, Laajalehto K, Linden M, et al.(2002) Effect of albumin and fibrinogen on calcium phosphate formation on sol-gel-derived titania coatings in vitro. Chem Mater 14: 1614-1621.
111. Cazalbou S, Combes C, Eichert D, Rey C, Glimcher MJ, (2004) Poorly crystalline apatites: evolution and maturation in vitro and in vivo. J Bone Miner Metab 22: 310-317.
112. Rees SG, Wassell DT, Shellis RP, Embery G, (2004) Effect of serum albumin on glycosaminoglycan inhibition of hydroxyapatite formation. Biomaterials 25: 971-977.
113. Vali H, McKee MD, Ciftcioglu N, Sears SK, Plows FL, et al.(2001) Nanoforms: a new type of protein-associated mineralization. Geochim Cosmochim Acta 65: 63-74.
114. Benzerara K, Miller VM, Barell G, Kumar V, Miot J, et al.(2006) Search for microbial signatures within human and microbial calcifications using soft x-ray spectromicroscopy. J Investig Med 54: 367-379.
115. Cartellieri S, Hamer O, Helmholz H, Niemeyer B, (2002) One-step affinity purification of fetuin from fetal bovine serum. Biotechnol Appl Biochem 35: 83-89.
116. Mahamid J, Sharir A, Addadi L, Weiner S, (2008) Amorphous calcium phosphate is a major component of the forming fin bones of zebrafish: Indications for an amorphous precursor phase. Proc Natl Acad Sci U S A 105: 12748-12753.
117. Nylen MU, Eanes ED, Termine JD, (1972) Molecular and ultrastructural studies of non-crystalline calcium phosphates. Calcif Tissue Res 9: 95-108.
118. Eanes ED, Termine JD, Nylen MU, (1973) An electron microscopic study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite. Calcif Tissue Res 12: 143-158.
119. Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, et al.(2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68: 145-154.
120. Evan AP, Coe FL, Lingeman JE, Worcester E, (2005) Insights on the pathology of kidney stone formation. Urol Res 33: 383-389.
121. Coe FL, Evan A, Worcester E, (2005) Kidney stone disease. J Clin Invest 115: 2598-2608.
122. Evan A, Lingeman J, Coe FL, Worcester E, (2006) Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69: 1313-1318.
123. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, et al.(2007) Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken) 290: 1315-1323.
124. Evan AP, Lingeman JE, Coe FL, Worcester EM, (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28: 111-119.
125. Evan AP, (2009) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol. In press.
126. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, et al.(2003) Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111: 607-616.
127. Carden A, Morris MD, (2000) Application of vibrational spectroscopy to the study of mineralized tissues (review). J Biomed Opt 5: 259-268.
128. Barrere F, van Blitterswijk CA, de Groot K, (2006) Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomedicine 1: 317-332.
129. Barralet J, Best S, Bonfield W, (1998) Carbonate substitution in precipitated hydroxyapatite: an investigation into the effects of reaction temperature and bicarbonate ion concentration. J Biomed Mater Res 41: 79-86.
130. Vallet-Regi M, Ramila A, (2000) New bioactive glass and changes in porosity during the growth of a carbonate hydroxyapatite layer on glass surfaces. Chem Mater 12: 961-965.
131. Aizenberg J, Lambert G, Addadi L, Weiner S, (1996) Stabilization of amorphous calcium carbonate by specialized macromolecules in biological and synthetic precipitates. Adv Mater 8: 222-226.
132. Raz S, Testeniere O, Hecker A, Weiner S, Luquet G, (2002) Stable amorphous calcium carbonate is the main component of the calcium storage structures of the crustacean Orchestia cavimana. Biol Bull 203: 269-274.
133. Ayman A, Talaat MS, Negm S, Talaat H, (2008) Investigation of biophysical characteristics of diabetic living eye tissues using PA-FTIR-spectroscopy. Eur Phys J Spec Top 153: 497-501.
134. Chen CW, Oakes CS, Byrappa K, Riman RE, Brown K, et al.(2004) Synthesis, characterization, and dispersion properties of hydroxyapatite prepared by mechanochemical-hydrothermal methods. J Mater Chem 14: 2425-2432.
135. Singh S, Bhardwaj P, Singh V, Aggarwal S, Mandal UK, (2008) Synthesis of nanocrystalline calcium phosphate in microemulsion-effect of nature of surfactants. J Colloid Interface Sci 319: 322-329.
136. Penel G, Leroy G, Rey C, Bres E, (1998) MicroRaman spectral study of the PO4 and CO3 vibrational modes in synthetic and biological apatites. Calcif Tissue Int 63: 475-481.
137. Kale S, Biermann S, Edwards C, Tarnowski C, Morris M, et al.(2000) Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol 18: 954-958.
138. Christoffersen J, Christoffersen MR, Kibalczyc W, Andersen FA, (1989) A contribution to the understanding of the formation of calcium phosphates. J Cryst Growth 94: 767-777.
139. Suvorova EI, Buffat PA, (1999) Electron diffraction from micro- and nanoparticles of hydroxyapatite. J Microsc 196: 46-58.
140. Suvorova EI, Buffat PA, (2001) Size effect in X-ray and electron diffraction patterns from hydroxyapatite particles. Crystallography Rep 46: 722-729.
141. Rochette CN, Rosenfeldt S, Heiss A, Narayanan T, Ballauff M, et al.(2009) A shielding topology stabilizes the early stage protein-mineral complexes of fetuin-A and calcium phosphate: a time-resolved small-angle X-ray study. Chembiochem 10: 735-740.
142. George A, Veis A, (2008) Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition. Chem Rev 108: 4670-4693.
143. Chen CC, Boskey AL, (1985) Mechanisms of proteoglycan inhibition of hydroxyapatite growth. Calcif Tissue Int 37: 395-400.
144. Eanes ED, Hailer AW, Midura RJ, Hascall VC, (1992) Proteoglycan inhibition of calcium phosphate precipitation in liposomal suspensions. Glycobiology 2: 571-578.
145. Eanes ED, Hailer AW, (1994) Effect of ultrafilterable fragments from chondroitinase and protease-treated aggrecan on calcium phosphate precipitation in liposomal suspensions. Calcif Tissue Int 55: 176-179.
146. Nancollas GH, Budz JA, (1990) Analysis of particle size distribution of hydroxyapatite crystallites in the presence of synthetic and natural polymers. J Dent Res 69: 1678-1685.
147. Zeng H, Chittur KK, Lacefield WR, (1999) Dissolution/reprecipitation of calcium phosphate thin films produced by ion beam sputter deposition technique. Biomaterials 20: 443-451.
148. He G, Dahl T, Veis A, George A, (2003) Dentin matrix protein 1 initiates hydroxyapatite formation in vitro. Connect Tissue Res 44: 240-245.
149. Serro AP, Bastos M, Pessoa JC, Saramago B, (2004) Bovine serum albumin conformational changes upon adsorption on titania and on hydroxyapatite and their relation with biomineralization. J Biomed Mater Res A 70: 420-427.
150. Doi Y, Eanes ED, Shimokawa H, Termine JD, (1984) Inhibition of seeded growth of enamel apatite crystals by amelogenin and enamelin proteins in vitro. J Dent Res 63: 98-105.
151. Aoba T, Fukae M, Tanabe T, Shimizu M, Moreno EC, (1987) Selective adsorption of porcine-amelogenins onto hydroxyapatite and their inhibitory activity on hydroxyapatite growth in supersaturated solutions. Calcif Tissue Int 41: 281-289.
152. Hunter GK, Curtis HA, Grynpas MD, Simmer JP, Fincham AG, (1999) Effects of recombinant amelogenin on hydroxyapatite formation in vitro. Calcif Tissue Int 65: 226-231.
153. Beniash E, Simmer JP, Margolis HC, (2005) The effect of recombinant mouse amelogenins on the formation and organization of hydroxyapatite crystals in vitro. J Struct Biol 149: 182-190.
154. Chen CC, Boskey AL, Rosenberg LC, (1984) The inhibitory effect of cartilage proteoglycans on hydroxyapatite growth. Calcif Tissue Int 36: 285-290.
155. Chen CC, Boskey AL, (1986) The effects of proteoglycans from different cartilage types on in vitro hydroxyapatite proliferation. Calcif Tissue Int 39: 324-327.
156. Linde A, Lussi A, (1989) Mineral induction by polyanionic dentin and bone proteins at physiological ionic conditions. Connect Tissue Res 21: 197-202.
157. Boskey AL, Spevak L, Doty SB, Rosenberg L, (1997) Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif Tissue Int 61: 298-305.
158. Waddington RJ, Roberts HC, Sugars RV, Schonherr E, (2003) Differential roles for small leucine-rich proteoglycans in bone formation. Eur Cell Mater 6: 12-21.
159. Sugars RV, Milan AM, Brown JO, Waddington RJ, Hall RC, et al.(2003) Molecular interaction of recombinant decorin and biglycan with type I collagen influences crystal growth. Connect Tissue Res 44: 189-195.
160. Midura RJ, Wang A, Lovitch D, Law D, Powell K, et al.(2004) Bone acidic glycoprotein-75 delineates the extracellular sites of future bone sialoprotein accumulation and apatite nucleation in osteoblastic cultures. J Biol Chem 279: 25464-25473.
161. Gorski JP, Wang A, Lovitch D, Law D, Powell K, et al.(2004) Extracellular bone acidic glycoprotein-75 defines condensed mesenchyme regions to be mineralized and localizes with bone sialoprotein during intramembranous bone formation. J Biol Chem 279: 25455-25463.
162. Hunter GK, Goldberg HA, (1993) Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci U S A 90: 8562-8565.
163. Hunter GK, Goldberg HA, (1994) Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J 302: 175-179.
164. Boskey AL, (1995) Osteopontin and related phosphorylated sialoproteins: effects on mineralization. Ann N Y Acad Sci 760: 249-256.
165. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA, (1996) Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317: 59-64.
166. Harris NL, Rattray KR, Tye CE, Underhill TM, Somerman MJ, et al.(2000) Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis. Bone 27: 795-802.
167. Malaval L, Wade-Gueye NM, Boudiffa M, Fei J, Zirngibl R, et al.(2008) Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205: 1145-1153.
168. Ganss B, Kim RH, Sodek J, (1999) Bone sialoprotein. Crit Rev Oral Biol Med 10: 79-98.
169. Stubbs JT 3rd, Mintz KP, Eanes ED, Torchia DA, Fisher LW, (1997) Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain. J Bone Miner Res 12: 1210-1222.
170. Baht GS, Hunter GK, Goldberg HA, (2008) Bone sialoprotein-collagen interaction promotes hydroxyapatite nucleation. Matrix Biol 27: 600-608.
171. Ye L, MacDougall M, Zhang S, Xie Y, Zhang J, et al.(2004) Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development. J Biol Chem 279: 19141-19148.
172. Ling Y, Rios HF, Myers ER, Lu Y, Feng JQ, et al.(2005) DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res 20: 2169-2177.
173. Tartaix PH, Doulaverakis M, George A, Fisher LW, Butler WT, et al.(2004) In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions. J Biol Chem 279: 18115-18120.
174. He G, Dahl T, Veis A, George A, (2003) Nucleation of apatite crystals in vitro by self-assembled dentin matrix protein 1. Nat Mater 2: 552-558.
175. Boskey AL, Maresca M, Doty S, Sabsay B, Veis A, (1990) Concentration-dependent effects of dentin phosphophoryn in the regulation of in vitro hydroxyapatite formation and growth. Bone Miner 11: 55-65.
176. Zanetti M, de Bernard B, Jontell M, Linde A, (1981) Ca2+-binding studies of the phosphoprotein from rat-incisor dentine. Eur J Biochem 113: 541-545.
177. Fujisawa R, Kuboki Y, Sasaki S, (1987) Effects of dentin phosphophoryn on precipitation of calcium phosphate in gel in vitro. Calcif Tissue Int 41: 44-47.
178. Suzuki S, Sreenath T, Haruyama N, Honeycutt C, Terse A, et al.(2009) Dentin sialoprotein and dentin phosphoprotein have distinct roles in dentin mineralization. Matrix Biol 28: 221-229.
179. Boskey A, Spevak L, Tan M, Doty SB, Butler WT, (2000) Dentin sialoprotein (DSP) has limited effects on in vitro apatite formation and growth. Calcif Tissue Int 67: 472-478.
180. Westenfeld R, Schafer C, Smeets R, Brandenburg VM, Floege J, et al.(2007) Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 22: 1537-1546.
181. Terkeltaub RA, Santoro DA, Mandel G, Mandel N, (1988) Serum and plasma inhibit neutrophil stimulation by hydroxyapatite crystals. Evidence that serum alpha 2-HS glycoprotein is a potent and specific crystal-bound inhibitor. Arthritis Rheum 31: 1081-1089.
182. Arvidsson A, Currie F, Kjellin P, Sul YT, Stenport V, (2009) Nucleation and growth of calcium phosphates in the presence of fibrinogen on titanium implants with four potentially bioactive surface preparations. An in vitro study. J Mater Sci Mater Med 20: 1869-1879.
183. Strate T, Knoefel WT, Yekebas E, Izbicki JR, (2003) Chronic pancreatitis: etiology, pathogenesis, diagnosis, and treatment. Int J Colorectal Dis 18: 97-106.
184. Bernard JP, Adrich Z, Montalto G, De Caro A, De Reggi M, et al.(1992) Inhibition of nucleation and crystal growth of calcium carbonate by human lithostathine. Gastroenterology 103: 1277-1284.
185. Patard L, Lallemand JY, Stoven V, (2003) An insight into the role of human pancreatic lithostathine. J Pancreas 4: 92-103.
186. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, et al.(1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81.
187. Murshed M, Schinke T, McKee MD, Karsenty G, (2004) Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 165: 625-630.
188. Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N, (1976) Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A 73: 1447-1451.
189. Menanteau J, Neuman WF, Neuman MW, (1982) A study of bone proteins which can prevent hydroxyapatite formation. Metab Bone Dis Relat Res 4: 157-162.
190. Boskey AL, Wians FH Jr, Hauschka PV, (1985) The effect of osteocalcin on in vitro lipid-induced hydroxyapatite formation and seeded hydroxyapatite growth. Calcif Tissue Int 37: 57-62.
191. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, et al.(1981) Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26: 99-105.
192. Romberg RW, Werness PG, Lollar P, Riggs BL, Mann KG, (1985) Isolation and characterization of native adult osteonectin. J Biol Chem 260: 2728-2736.
193. Doi Y, Okuda R, Takezawa Y, Shibata S, Moriwaki Y, et al.(1989) Osteonectin inhibiting de novo formation of apatite in the presence of collagen. Calcif Tissue Int 44: 200-208.
194. Fujisawa R, Wada Y, Nodasaka Y, Kuboki Y, (1996) Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals. Biochim Biophys Acta 1292: 53-60.
195. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, et al.(1993) Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22: 147-159.
196. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, et al.(2002) Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161: 2035-2046.
197. Nishio S, Hatanaka M, Takeda H, Aoki K, Iseda T, et al.(2000) Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin. Mol Urol 4: 383-390.
198. Raj PA, Johnsson M, Levine MJ, Nancollas GH, (1992) Salivary statherin. Dependence on sequence, charge, hydrogen bonding potency, and helical conformation for adsorption to hydroxyapatite and inhibition of mineralization. J Biol Chem 267: 5968-5976.
199. Wikiel K, Burke EM, Perich JW, Reynolds EC, Nancollas GH, (1994) Hydroxyapatite mineralization and demineralization in the presence of synthetic phosphorylated pentapeptides. Arch Oral Biol 39: 715-721.
200. Shaw WJ, Long JR, Campbell AA, Stayton PS, Drobny GP, (2000) A solid state NMR study of dynamics in a hydrated salivary peptide adsorbed to hydroxyapatite. J Am Chem Soc 122: 7118-7119.
201. Mo L, Huang HY, Zhu XH, Shapiro E, Hasty DL, et al.(2004) Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 66: 1159-1166.
202. Hess B, (1992) Tamm-Horsfall glycoprotein-inhibitor or promoter of calcium oxalate monohydrate crystallization processes? Urol Res 20: 83-86.
203. Chen WC, Lin HS, Chen HY, Shih CH, Li CW, (2001) Effects of Tamm-Horsfall protein and albumin on calcium oxalate crystallization and importance of sialic acids. Mol Urol 5: 1-5.
204. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, et al.(1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci U S A 89: 426-430.
205. Toroian D, Price PA, (2008) The essential role of fetuin in the serum-induced calcification of collagen. Calcif Tissue Int 82: 116-126.
206. Boskey AL, (2008) Mechanism of mineralization of collagen-based connective tissues. In: Sigel A, Sigel H, Sigel RKO, editors. Metal ions in life sciences. Volume 4. Biomineralization. From nature to application Hoboken John Wiley & Sons pp. 457-505.
207. Price PA, June HH, Hamlin NJ, Williamson MK, (2004) Evidence for a serum factor that initiates the re-calcification of demineralized bone. J Biol Chem 279: 19169-19180.
208. Hamlin NJ, Price PA, (2004) Mineralization of decalcified bone occurs under cell culture conditions and requires bovine serum but not cells. Calcif Tissue Int 75: 231-242.
209. Price PA, Chan WS, Jolson DM, Williamson MK, (2006) The elastic lamellae of devitalized arteries calcify when incubated in serum: evidence for a serum calcification factor. Arterioscler Thromb Vasc Biol 26: 1079-1085.
210. Price PA, Toroian D, Chan WS, (2009) Tissue-nonspecific alkaline phosphatase is required for the calcification of collagen in serum: a possible mechanism for biomineralization. J Biol Chem 284: 4594-4604.
211. Parfitt AM, (2001) The bone remodeling compartment: a circulatory function for bone lining cells. J Bone Miner Res 16: 1583-1585.
212. Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F, (2001) Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 16: 1575-1582.
213. Anderson HC, Garimella R, Tague SE, (2005) The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 10: 822-837.
214. Boskey AL, (1998) Biomineralization: conflicts, challenges, and opportunities. J Cell Biochem Suppl 30-31: 83-91.
215. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, et al.(2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15: 2857-2867.
216. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, et al.(2005) Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16: 2920-2930.
217. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM, (2005) Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20: 22-27.
218. Omelon S, Georgiou J, Henneman ZJ, Wise LM, Sukhu B, et al.(2009) Control of vertebrate skeletal mineralization by polyphosphates. PLoS One 4: e5634.
219. Samoylov AM, Samoylova TI, Pustovyy OM, Samoylov AA, Toivio-Kinnucan MA, et al.(2005) Novel metal clusters isolated from blood are lethal to cancer cells. Cells Tissues Organs 179: 115-124.
220. Vodyanoy V, Pustovyy O, Vainrub A, (2007) High resolution light microscopy of nanoforms. Proc Soc Photo Opt Instrum Eng 6694: 1-12.
221. Addadi L, Politi Y, Nudelman F, Weiner S, (2008) Biomineralization design strategies and mechanisms of mineral formation: operating at the edge of instability. In: Novoa JJ, Braga D, Addadi L, editors. Engineering of crystalline materials properties. State of the art in modeling design and applications Dordrecht Springer pp. 1-15.
222. Fang J-Y, Fang C-L, Liu C-H, Su Y-H, (2008) Lipid nanoparticles as vehicles for tropical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharmaceut Biopharmaceut 70: 633-640.
223. Ma YH, Wu SY, Wu T, Chang YJ, Hua MY, et al.(2009) Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles. Biomaterials 30: 3343-3351.